Heborium Group Update on the Signed Letter of Intent With China Health Resources Inc

Phase 1 of due diligence process for the sale of up to 100% of Herborium Group is underway   TEANECK, N.J., March 2, 2012 /PRNewswire/ -- Herborium Group, Inc. (HBRM.PK) www.herborium.com is pleased to announce that the process of Phase 1 due diligence for the sale of up to 100% interest to China Health Resources Inc (OTCBB:CHRI) is underway. "We are very excited to advise that the process has begun and is moving along smoothly," stated Dr. Agnes P. Olszewski CEO of Herborium Group "As w...continued CHRI HBRM  chinese pharmaceutical naturopathic

URL: http://www.investorpoint.com/news/INTHPINK/48984128/